Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Agargun MY, Kara H, Ozbek H, Tombul T, Ozer OA (2002) Restless legs syndrome induced by mirtazapine. J Clin Psychiatr 63(12): 1179
Ansoms C, Backer-Dierick GD, Vereecken JL (1977) Sleep disorders in patients with severe mental depression: double-blind placebo-controlled evaluation of the value of pipamperone (Dipiperon). Acta Psychiatr Scand 55(2): 116–122
Asian S, Isik E, Cosar B (2002) The effects of mirtazapine on sleep: a placebo controlled, double-blind study in young healthy volunteers. Sleep 25(6): 677–679
Atzpodien J, Kuchler T, Wandert T, Reitz M (2003) Rapid deterioration in quality of live during interleukin-2-and alpha-interferon-based home therapy of renal cell carcinoma is associated with good outcome. Br J Cancer 89(1): 50–54
Bazil CW, Castro LHM, Walczak TS (2000) Diurnal and nocturnal seizures reduce REM in patients with temporal lobe epilepsy. Arch Neurol 57: 363–368
Bell C, Wilson S, Rich A, Bailey J, Nutt D (2003) Effects on sleep architecture of pindolol, paroxetine and their combination in healthy volunteers. Psychopharmacology (Berl) 166(2): 102–110
Benington JH, Heller HC (1995) Monoaminergic and cholinergic modulation of REM-sleep timing in rat. Brain Res 681(1–2): 141–146
Benlucif S, Bauer GL, Dubocovich ML, Finkel SI, Zee PC (1999) Nimodipine potentiates the light-induced suppression of melatonin. Neurosci Lett 272(1): 67–71
Berger K (2003) Non-opioid analgesics and the risk of restless leg syndrome — a spurious association? Sleep 4(4): 351–352
Betts TA, Alford C (1985) Beta-blockers and sleep: a controlled trial. Eur J Clin Pharmacol 28Suppl: 65–68
Billard M, Besset A, Montplaisir J, Laffront F, Goldenberg F, Weill JS, Lubin S (1994) Mod-afinil: A double-blind multicentric study. Sleep 17: S107–S112
Billiard M (1987) Lithium carbonate: effects on sleep patterns of normal and depressed subjects and its use in sleep-wake pathology. Pharmacopsychiatry 20(5): 195–196
Bjorvatn B, Ursin R (1998) Changes in sleep and wakefulness following 5-HT1A ligands given systemically and locally in different brain regions. Rev Neurosci 9(4): 265–273
Blois R, Gaillard JM (1990) Effects of moclobemide on sleep in healthy human subjects. Acta Psychiatr Scand Suppl 360: 73–75
Bolhalter S, Murck H, Holsboer F, Steiger A (1997) Cortisol enhances sleep and growth hormone secretion in elderly people. Neurobiol Aging 18(4): 423–429
Bracco D, Morin O, Liang H, Jequier E, Burger AG, Schutz Y (1996) Changes in sleep and energy expenditure and substrate oxidation induced by short term thyroxin administration in man. Obesity Research 4: 213–219
Breckenridge A (1991) Angiotensin converting enzyme inhibitors and quality of live. Am J Hypertens 4 (1 Pt 2): 79S–82S
Brodsky MA, Godbold J, Roth T, Olanow CW (2003) Sleepiness in Parkinson’s disease: a controlled study. Mov Disord 18(6): 668–672
Brown R, Price RJ, King MG, Husband AJ (1988) Autochthonous intestinal bacteria and coprophagy: a possible contribution to the ontology and rhythmicity of slow wave sleep in mammals. Med Hypotheses 26(3): 171–175
Brown R, Price RJ, King MG, Husband AJ (1990) Are antibiotic effects on sleep behaviour in the rat due to modulation of gut bacteria? Physiol Behav 48(4): 561–565
Carbon C (2001) Comparsion of side effects of levofloxacin versus other fluoroquinolones. Chemotherapy 47(Suppl 3): 9–14
Carskadon MA, Cavallo A, Rosekind MR (1989) Sleepiness and nap sleep following a morning dose of clonidine. Sleep 12(4): 338–344
Cathala HP Autret A (1978) Action of tiapride on wakefulness. Sem Hop 54(5–8): 353–357
Chouinard G, Bradwejn J, Annable L, Jones BD, Ross-Chouinard A (1984) Withdrawl symptoms after long-term treatment with low-potency neuroleptics. J Clin Psychiat 45(12): 500–502
Ciftci TU, Kokturk O, Bukan N, Bilgihan A (2004) The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome. Cytokine 28(2): 87–91
Croog SH, Levine S, Testa MA, Brown B, Bulpitt CJ, Jenkins CD, Klerman GL, Williams GH (1986) The effects of antihypertensive therapy on the quality of live. N Engl J Med 314(26): 1657–1664
Dahlof C, Dimenas E (1992) General well-being during treatment with different ACE-inhibitors: two double-blind placebo-controlled cross-over studies in healthy volunteers. Eur J Clin Pharmacol 43(3): 375–379
Dalla Volta G, Magoni M, Cappa S, Di Monda V (1990) Insomnia and perceptual disturbances during flunarizine treatment. Headache 30(2): 62–63
Danchin N, Genton P, Atlas P, Anconina J, Leclere J, Cherrier F (1995) Comparative effects of atenolol and clonidine on polygraphically recorded sleep in hypertensive men: a randomized, double-blind, crossover study. Int J Clin Pharmacol Ther 33(1): 52–55
Dimsdale JE, Newton RP (1992) Cognitive effects of beta blockers. J Psychosom Res 36(3): 229–236
Drake ME, Pakalnis A, Bogner JE, Andrews JM (1990) Outpatient sleep recording during antiepileptic drug monotherapy. Clin Electroencephalogr 21(3): 170–173
Dugovic C (1992) Functional activity of 5-HT2 receptors in the modulation of the sleep/wakefulness states. J Sleep Res 1(3): 163–168
Dunn NR, Pearce GL, Shakir SA (2000) Adverse effects associated with the use of donepezil in general practice in England. J Psychopharmacol 14(4): 406–408
Eddy M, Walbroehl GS (1999) Insomnia. Am Fam Physician 59(7): 1911–1916
Ehrinpreis MN, Dhar R, Narula A (1989) Cimitidine-induced galactorrhea. Am J Gastroenterol 84(5): 563–565
Eicher H, Hilgert D, Zeech J, Platt D, Becker C, Mutschler E (1992) Pharmacokinetics of nimodipine in multimorbid elderly patients with chronic brain failure. Arch Gerontol Geriatr 14(3): 309–319
Festi D, Sandri L, Mazzella G, Roda E, Sacco T, Staniscia T, Capodicasa S, Vestito A, Colecchia A (2004) Safety of interferon beta treatment for chronic HCV hepatitis. World J Gastroenterol 10(1): 12–16
Ficca G, Salzarulo P (2004) What in sleep is for memory. Sleep Med 5(3): 225–230
Finnimore AJ, Roebuck M, Sajkov D, McEvoy RD (1995) The effect of the GABA agonist, baclofen, on sleep and breathing. Eur Respi J 8(2): 230–234
Fitzpatrick MF, Engleman HM, Boellert HF, McHardy R, Shapiro CM, Deary IJ, Douglas NJ (1992) Effect of therapeutic theophylline levels on the sleep quality and daytime cognitive performance of normal subjects. Am Rev Respir Dis 145(6): 1355–1358
Foldvary N, Perry M, Lee J, Dinner D, Morris HH (2001) The effects of lamotrigine on sleep in patients with epilepsy. Epilepsia 42: 1569–1573
Foldvary-Schaefer N, De Leon Sanchez I, Karafa M, Mascha E, Dinner D, Morris HH (2002) Gabapentin increases slow wave sleep in normal adults. Epilepsia 43: 1493–1497
Friston KJ, Sharpley AL, Solomon RA, Cowen PJ (1989) Lithium increases slow wave sleep: possible mediation by brain 5-HT2 receptors? Psychopharmacology (Berl.) 98(1): 139–140
Gaillard JM (1985) Brain noradrenergic activity in wakefulness and paradoxical sleep: the effect of clonidine. Neuropsychopharmacology 13(1): 23–25
Galetin A, Clarke SE, Houston JB (2003) Multisite kinetic analysis of interactions between prototypical CYP3A4 subgroup substrates: midazolam, testosterone, and nifidipine. Drug Metab Dispos 31(9): 1108–1116
Gengo FM, Gabos C (1988) Central nervous system considerations in the use of beta-blockers, angiotensin-converting enzyme inhibitors, and thiazide diuretics in managing essential hypertension. Am Heart J 116 (1 Pt 2): 305–310
Gentili A, Godschalk MF, Gheorghiu D, Nelson K, Julius DA, Mulligan T (1996) Effect of clonidine and yohimbine on sleep in healthy men: a double-blind, randomized, controlled trial. Eur J Clin Pharmacol 50(6): 463–465
Gershanovich M, Kolygin B, Pirgach N (1993) Tropisetron in the control of nausea and vomiting induced by combined cancer chemotherapy in children. Ann Oncol 4Suppl 3: 35–37
Gigli GL, Placidi F, Diomedi M, Maschio M, Silvestri G, Scalise A, Marciani G (1997) Nocturnal sleep and daytime somnolence in untreated patients with temporal lobe epilepsy: changes after treatment with controlled-release carbamazepine. Epilepsia 38: 696–701
Girault C, Muir JF, Mihaltan F, Borderies P, De La Giclais B, Verdure A, Samson-Dollfus D (1996) Effects of repeated administration of zolpidem on sleep, diurnal and nocturnal respiratory function, vigilance, and physical performance in patients with COPD. Chest 110(5): 1203–1211
Gowing L, Ali R, White J (2002) Buprenorphine for the management of opioid withdrawl. Cochrane Database Syst Rev (2):CD002025
Greenberg DB, Gray JL, Mannix CM, Eisenthal S, Carey M (1993) Treatment-related fatigue and serum interleukin-1 levels in patients during external beam irradiation for prostate cancer. J Pain Symptom Manage 8(4): 196–200
Greenhill L, Puig-Antich J, Goetz R, Hanlon C, Davies M (1983) Sleep architecture and REM sleep measures in prepubertal children with attention deficit disorder with hyperactivity. Sleep 6(2): 91–101
Guilleminault C, Flagg W (1984) Effect of baclofen on sleep-related periodic leg movements. Ann Neurol 15(3): 234–239
Hohagen F, Lis S, Riemann D et al. (1994) Influence of biperiden and bomaprine on sleep in healthy subjects. Neuropsychopharmacology 11: 29–32
Holsboer-Trachsler E, Hatzinger M, Stohler R et al. (1993) Effects of the novel Acetylcho-linesterase inhibitor SDZ ENA 713 on sleep in man. Neuropsychopharmacology 8(1): 87–92
Home JA (1989) Aspirin and nonfebril waking oral temperature in healthy men and women links with SWS changes? Sleep 12(6): 516–521
Home JA, Percival JE, Traynor JR (1980) Aspirin and human sleep. Electroencephalogr Clin Neurophysiol 49(3–4): 409–413
Hotta I, Yamawaki S, Segawa T (1986) Long-term lithium treatment causes serotonin receptor down-regulation via serotonergic presynapses in rat brain. Neuropsychobiology 16(1): 19–26
Hu K, Li Q, Yang J, Hu S, Chen X (2003) The effect of theophylline on sleep-disordered breathing in patients with stable chronic congestive heart failure. Chin Med J (Engl) 116(11): 1711–1716
Hughes K, Glass C, Ripchinski M et al. (2003) Efficacy of the topical nasal steroid budesonide on improving sleep and daytime somnolence in patients with perennial allergic rhinitis. Allergy 58(5): 380–385
Ihl R (2003) The impact of drugs against dementia on cognition in aging and mild cognitive impairment. Pharmacopsychiatry 36Suppl 1: S38–43
Inglis F (2002) The tolerability and safety of cholinesterase inhibitors in the treatment of dementia. Int J Clin Pract Suppl 127: 45–63
Jarrott B, Lewis S, Conway EL, Summers R, Louis WJ (1984) The involvement of central alpha adrenoceptors in the antihypertensive actions of methyldopa and clonidine in the rat. Clin Exp Hypertens A 6(1–2): 387–400
Jarvis B, Figgitt DP (2003) Memantine. Drugs Aging 20(6): 465–467
Jeste DV, Caligiuri MP (1993) Tardive dyskinesia. Schizophr Bull 19(2): 303–315
Jindal RD, Fasiczka AL, Himmelhoch JM, Mallinger AG, Thase ME (2003 a) Effects of tranylcypromine on the sleep of patients with anergic bipolar depression. Psychopharmacol Bull 37(3): 118–126
Jindal RD, Friedman ES, Berman SR, Fasiczka AL, Howland RH, Thase ME (2003 b) Effects of sertraline on sleep architecture in patients with depression. J Clin Pharmacol 23(6): 540–548
Kanbayashi T, Sugiyama T, Aizawa R et al. (2002) Effects of donepezil (Aricept) on the rapid eye movement sleep of normal subjects. Psychiatry Clin Neurosci 56(3): 307–308
Kanno O, Clarenbach P (1985) Effct of clonidine and yohimbine on sleep in man: poly-graphic study and EEG analysis by normalized slope descriptors. Electroencephalogr Clin Neurophysiol 60(6): 478–484
Kanno O, Watanabe H, Kazamatsuri H (1993) Effects of zopiclone, flunitrazepam, triazolam and levomepromazine on the transient change in sleep-wake schedule: polygraphic study, and the evaluation of sleep and daytime condition. Prog Neuropsychopharmacol Biol Psychiatry 17(2): 229–239
Kaplan J, Fredrickson PA, Renaux SA, O’Brian PC (1993) Theophylline effect on sleep in normal subjects. Chest 103(1): 193–195
Kaynak D, Kiziltan G, Kaynak H, Benbir G, Uysal O (2005) Sleep and sleepiness in patients with Parkinson’s disease before and after dopaminergic treatment. Eur J Neurol 12(3):199–207
Kemme MJ, vd Post JP, Schoemaker RJ, Straub M, Cohen AF, van Gerven JM (2003) Central nervous system effects of moxonidine experimental sustained release formulation in patients with mild to moderate essential hypertension. Br J Pharmacol 55(6): 518–525
Kim EJ, Jeong DU (1999) Transdermal scopolamine alters phasic REM activity in normal young adults. Sleep 22(4): 515–520
Kirby R, Jardin A (1997) Doxazosin in the treatment of benign prostatic hyperplasia. A review of safety profile in older patients. Prostate Cancer Prostatic Dis 1(2): 84–89
Klein E, Mairaz R, Pascal M, Hefez A, Lavie P (1991) Discontinuation of lithium treatment in remitted bipolar patients: relationship between clinical outcome and changes in sleep-wake cycles. J Nerv Ment Dis 179(8): 449–501
Kleinlogel H (1989) Effects of the selective alpha 1-adrenoceptor blocker Prazosin on EEG sleep and waking stages in the rat. Neuropsychobiology 21(2): 100–103
Klemfuss H (1992) Rhythms and the pharmacology of lithium. Pharmacol Ther 56(1): 53–78
Knigge U, Dejgaard A, Wollesen F, Thuesen B, Christiansen PM (1982) Histamine regulation of prolactin secretion through H1-and H2-receptors. J Clin Endocrinol Metab 55(1): 118–122
Korner Y, Meindorfner C, Moller JC et al. (2004) Predictors of sudden onset of sleep in Parkinson’s disease. Mov Disord 19(11): 1298–1305
Kostis JB, Rosen RC, Holzer BC, Randolph C, Taska LS, Miller MH (1990) CNS side effects of centrally-active antihypertensive agents: a prospective, placebo-controlled study of sleep, mood state, and cognitive and sexual function in hypertensive males. Psychopharmacology (Berl.) 102(2): 163–170
Kravitz HM, Corcos DM, Hansen G, Penn RD, Cartwright RD, Gianino J (1992) Intrathecal baclofen. Effects on nocturnal leg muscle spasticity. Am J Phys Med Rehabil 71(1): 48–52
Kretzschmar R, Otto J, Teschendorf HJ, Worstmann W (1976) Pharmacological investigations of 4′-fluoro-4-(4-methyl-peperidono)-butyrophenone with respect to its sedative and sleep-inducing properties (author’s translation). Arzneimittelforschung 26(6): 1073–1076
Krueger JM, Dinarello CA, Shoham S, Davenne D, Walter J, Kubillus S (1987) Interferon alpha-2 enhances slow-wave sleep in rabbits. Int J Immunopharmacol 9(1): 23–30
Landolt HP, Meier V, Burgess HJ, Finelli LA, Cattelin F, Achermann P, Borbely AA (1999) Serotonin-2 receptors and human sleep: effect of a selective antagonist on EEG power spectra. Neuropsychopharmacology 21(3): 455–466
LaRochelle JS, Karp BI (2004) Restless legs syndrome due to interferon-alpha. Mov Disord 19(6): 730–731
Lee JH, Woo JI, Meltzer HJ (2001) Effects of clozapine on sleep measures and sleep-associated changes in growth hormone and cortisol in patients with schizophrenia. Psychiatry Res 103(2–3): 157–166
Lepor H, Knapp-Maloney G, Sunshine H (1990) A dose titration study evaluating terazosin, a selective, once-a-day alpha 1-blocker for the treatment of symptomatic benign prostatic hyperplasia. J Urol 144(6): 1393–1398
Luthringer R, Toussaint M, Schaltenbrand N, Bailey P, Danjou PH, Hackett D, Guichoux JY, Macher JP (1996) A double-blind, placebo-controlled evaluation of the effects of orally administered venlafaxine on sleep in inpatients with major depression. Psychopharmacol Bull 32(4): 637–646
MacDonald R, Wilt TJ, Howe RW (2004) Doxazosin for treating lower urinary tract symptoms compatible with benign prostatic obstruction: a systematic review of efficacy and adverse effects. BJU Int 94(9): 1263–1270
Maddock C, Baita A, Orru MG et al. (2004) Psychopharmacological treatment of depression, anxiety, irritability and insomnia in patients receiving interferon-alpha: a prospective case series and a discussion of biological mechanisms. J Psychopharmacol 18(1): 41–46
Man GC, Champman KR, Ali SH, Darke AC (1996) Sleep quality and nocturnal respiratory function with once-daily theophylline (Uniphyl) and inhalated salbutamol in patients with COPD. Chest 110(3): 648–653
Manni R, Terzaghi M, Sartori I, Mancini F, Pacchetti C (2004) Dopamine agonists and daytime sleepiness in PD: review of the literature and personal findings. Sleep Med 5(2): 189–193
Manning C, Scandale L, Manning EJ, Gengo FM (1992) Central nervous system effects of meclizine and dimenhydrinate: evidence of acute tolerance to antihistamines. J Clin Pharmacol 32(11): 996–1002
Maurizi CP (1984) A mechanism of mania and the chemistry of dreams: a hypothesis. South Med J 77(12): 1491–1493
McLoughlin J, Miller AJ (1993) Metoclopramide in the treatment of reflux oesophagitis: a comparison of normal and controlled-release formulations. Curr Med Res Opin 13(3): 145–153
Metz LM, Patten SB, Archibald CJ et al. (2004) The effect of immunomodulatory treatment on multiple sclerosis fatigue. J Neurol Neurosur Ps 75(7): 1045–1047
Minvielle S (2000) Klein-Levin syndrome: a neurological disease with psychiatric symptoms. Encephale 26(4): 71–74
Mizuno S, Kameda A, Inagaki T, Horiguchi J (2004) Effects of donepezil on Alzheimer’s disease: the relationship between cognitive function and rapid eye movement sleep. Psychiatry Clin Neurosci 58(6): 660–665
Monti JM (1987) Disturbances of sleep and wakefulness associated with the use of anti-hypertensive agents. Life Sci 41(17): 1979–1988
Monti JM, Alterwain P, Monti D (1990) The effect of moclobemide on nocturnal sleep of depressed patients. J Affect Disord 20(3): 201–208
Monti JM, Monti D (2004) Sleep in schizophrenia patients and the effects of antipsychotic drugs. Sleep Med Rev 8(2): 133–148
Mulloy E, McNicholas WT (1993) Theophylline improves gas exchange during rest, exercise, and sleep in severe chronic obstructive pulmonary disease. Am Rev Respir Dis 148 (4 Pt 1): 1030–1036
Murphy PJ, Badia P, Myres BL, Boecker MR, Wright KP jr. (1994) Nonsteroidal anti-inflammatory drugs affect normal sleep patterns in humans. Physiol Behav 55(6): 1063–1066
Murphy PJ, Myres BL, Badia P (1996) Nonsteroidal anti-inflammatory drugs alter body temperature and suppress melatonin in humans. Physiol Behav 59(1): 133–139
Naito K, Osama H, Ueno R, Hayaishi O, Honda K, Inoue S (1988) Suppression of sleep by prostaglandin synthesis inhibitors in unrestrained rats. Brain Res 453(1–2): 329–336
Nakazawa Y, Kotorii M, Kotorii T, Ohshima M, Hasuzawa H (1977) Individual variations in response of human REM sleep to amitriptyline and haloperidol. Electroencephalogr Clin Neurophysiol 42(6): 769–775
Nance PW, Bugaresti J, Shellenberger K, Sheremata W, Martinez-Arizala A (1994) Efficacy and safety of tizanidine in the treatment of spasticity in patients with spinal cord injury. North American Tizanidine Study Group. Neurology 44(11 Suppl 9): S44–S51
Neckelmann D, Bjorvatn B, Bjorkum AA, Ursin R (1996) Citalopram: differential sleep/wake and EEG power spectrum effects after single dose and chronic administration. Behav Brain Res 79(1–2): 183–192
Nolen WA, Haffmans PM, Bouvy PF, Duivenvoorden HJ (1993) Monoamine oxidase inhibitors in resistant major depression. A double-blind comparison of brofaromine and tranylcypramine in patients resistant to tricyclic antidepressant. J Affect Disord 28(3): 189–197
Norrby SR (1991) Side-effects of quinolones: comparison between quinolones and other antibiotics. Eur J Clin Microbiol Infect Dis 10(4): 378–383
Obermeyer WH, Benca RM (1996) Effects of drugs on sleep. Neurol Clin 14: 827–840
Onofrj M, Luciano AL, Iacono D, D’Andreamatteo G (2003) Mirtazapine induces REM sleep behaviour disorder (RBD) in parkinsonism. Neurology 60(1): 113–115
Orr WC, Duke JC, Imes NK, Mellow MH (1994) Comparative effects of H2-receptor antagonists on subjective and objective assessments of sleep. Aliment Pharmacol Ther 8(2): 203–207
Pantoni L, de Ser T, Soglian AG, Amigoni S, Spadari G, Binelli D, Inzitari D (2005) Efficacy and safety of nimodipine in subcortical vascular dementia: a randomized placebo-controlled trial. Stroke 36(3): 619–624
Paus S, Brecht HM, Koster J, Seeger G, Klockgether T, Wullner U (2003) Sleepattacks, daytime sleepiness, and dopamine agonists in Parkinson’s disease. Mov Disord 18(6): 659–667
Peskind ER, Bonner LT, Hoff DJ, Raskind MA (2003) Prazosin reduces trauma-related nightmares in older men with chronic posttraumatic stress disorder. J Geriatr Psychiatry Neurol 16(3): 165–171
Pickworth WB, Neidert GL, Kay DC (1981) Morphinlike arousal by methadone during sleep. Clin Pharmacol Ther 30(6): 796–804
Placidi F, Diomedi M, Scalise A, Marciniani MG, Romigi A, Gigli GL (2000) Effect of anti-convulsants on nocturnal sleep in epilepsy. Neurology 54: S25–S32
Poland RE, McCracken JT, Lutchmansingh Petal. (1997) Differential response of rapid eye movement sleep to cholinergic blockade by scopolamine in currently depressed, remitted, and normal control subjects. Biol Psychiatry 41(9): 929–938
Pollmacher T, Schreiber W, Gudwill S et al. (1993) Influence of endotoxin on nocturnal sleep in humans. Am J Physiol 264 (6 PT 2): R1077–1083
Poole MD, Postma DS (1991) Characterization of cough associated with angiotensin-converting enzyme inhibitors. Otolaryngol Head Neck Surg 105(5): 714–716
Poppe M, Friebel D, Reuner U, Todt H, Koch R, Heubner G (2003) The Kleine-Levin syndrome effects of treatment with lithium. Neuropediatrics 34(3): 113–119
Prendiville J, Thatcher N, Lind M, Mclntosh R, Ghosh A, Stern P, Crowther D (1993) Recombinant human interleukin-4 (rhu IL-4) administered by the intravenous and subcutaneous routs in patients with advanced cancer — a phase I toxicity study and pharmacokinetic analysis. Eur J Cancer 29A(12): 1700–1707
Prichard BN (1994) Clinical experience with moxonidine. Cardiovasc Drugs Ther 8Suppl 1: 49–58
Prisant FL, Spruill WJ, Fincham JE, Wade WE, Carr AE, Adams MA (1991) Depression associated with antihypertensive drugs. J Fam Pract 33(5): 481–485
Radulovacki M, Trobovic SM, Carley DW (1998) Serotonin 5-HT3-receptor antagonist GR 38032F suppresses sleep apneas in rat. Sleep 21(2): 131–136
Rampello L, Raffaele R, Nicoletti G, Le Pira F, Vecchio I, Malaguarnera M, Drago F (1997) Neurobehavioral syndrome induced by H2-receptor blocker withdrawl: possible role of prolactin. 20(1): 49–50
Rao U, Lutchmansingh P, Poland RE (1999) Age-related effects of scopolamine on REM sleep regulation in normal control subjects: relationship to sleep abnormalities in depression. Neuropsychopharmacology 21(6): 723–730
Raskind MA, Peskind ER, Kanter ED et al. (2003) Reduction of nightmares and other PTSD symptoms in combat veterans by Prazosin: a placebo-controlled study. Am J Psychiatry 160(2): 371–373
Richardson GS, Roehrs TA, Rosenthal L, Koshorek G, Roth T (2002) Tolerance to daytime sedative effects of HI antihistamines. J Clin Psychopharmacol 22(5): 511–515
Riemann D, Voderholzer U, Cohrs S et al. (2002) Trimipramine in primary insomnia: results of a poysomnographic double-blind controlled study. Pharmacopsychiatry 35(5): 165–174
Rijnbeek B, de Visser SJ, Franson KL, Cohen AF, van Gerven JM (2003) REM sleep effects as a biomarker for the effects of antidepressants in healthy volunteers. J Psychopharmacol 17(2): 196–203
Rizzo MA, Hadjimichael OC, Preiningerova J, Vollmer TL (2004) Prevalence and treatment of spasticity reported by multiple sclerosis patients. Mult Scler 10(5): 589–595
Rodgers PT, Brengel GR (1998) Famotidine associated mental status changes. Pharmacotherapy 18(2): 404–407
Romigi A, Brusa L, Marciani MG et al. (2004) Sleep episodes and daytime sleepiness as result of individual susceptibility to different dopaminergic drugs in a PD patient: a polysomnographic study. J Neurol Sci 228(1): 7–10
Rosenthal T, Algom M, Chagnac A, Grossman E, Kisch E, Leiba M, Paran E (1986) Captopril as a replacement therapy in hypertension improving quality of life — a multicentre study. Postgrad Med J 62(Suppl 1): 114–115
Ross JS, Shua-Haim JR (1998) Aricept-induced nightmares in Alzheimer’s disease: 2 case reports. J Am Geriatr Soc 46(1): 119–120
Rothe B, Guldner J, Hohlfeldt E, Lauer CJ, Pollmacher T, Holsboer F, Steiger A (1994) Effects of 5HT3 receptor antagonism by tropisetron on the sleep EEG and on nocturnal hormone secretion. Neuropsychopharmacology 11(2): 101–106
Sagales T, Erill S, Domino EF (1975) Effects of repeated doses of scopolamine on the electroencephalographic stages of sleep in normal volunteers. Clin Pharmacol Ther 18(06): 727–732
Saletu B, Frey R, Krupka M, Anderer P, Grundberger J, Barbanjo M (1989) Differential effects of a new central adrenergic agonist — modafinil — and D-amphetamine on sleep and early morning behaviour in young healthy volunteers. Int J Clin Pharmacol Res 9(3): 183–195
Salin-Pascual RJ, Galicia-Polo L, Drucker-Colin R (1997) Sleep changes after 4 consecutive days of venlafaxine administration in normal volunteers. J Clin Psychiatr 58(8): 348–350
Salinsky MC, Oken BS, Binder LM (1996) Assessment of drowsiness in epilepsy patients receiving chronic antiepileptic drug therapy. Epilepsia 37: 181–187
Sanchez-Romero A, Garcia-Delgado R, Duran-Quintana JA (2003) Can treatment associated with ticlopidine and nifidipine increase levels of phenobarbital? Rev Neurol 36(5): 433–434
Santens P (2003) Sleep attacks in Parkinson’s disease induced by Entacapone, a COMT-inhibitor. Fundam Clin Pharmacol 17(1): 121–123
Sawada T, Sako K, Yoshihara K, Nakamura K, Yokohama S, Hayashi M (2003) Timed-release formulation to avoid drug-drug interaction between diltiazem and midazolam. J Pharm Sci 92(4): 790–797
Schoenberger JA, Croog SH, Sudilovsky A, Levine S, Baume RM (1990) Self-reported side effects from antihypertensive drugs. A clinical trial. Quality of life research group. Am J Hypertens 3(2): 123–132
Schook CE, Radtke H, Wurst W, Thieme G (1989) Overview of clinical trials with Urapidil. Am J Cardiol 64(7): 30D–37D
Schredl M, Weber B, Braus D, Gattaz WF, Berger M, Riemann D, Heusler I (2000) The effect of rivastigmine on sleep in elderly healthy subjects. Exp Gerontol 35(2): 243–249
Schredl M, Weber B, Leins ML, Heuser I (2001) Donepezil-induced REM sleep augmentation enhances memory performance in elderly, healthy persons. Exp Gerontol 36(2): 353–361
Schwid SR, Goodman AD, Mattson DH (1997) Autoimmune hyperthyreoidism in patients with multiple sclerosis treated with interferon beta-1 b. Arch Neurol 54(9): 1169–1190
Selby C, Engleman HM, Fitzpatrick MF, Sime PM, Mackay TW, Douglas NJ (1997) Inhaled salmeterol or oral theophylline in nocturnal asthma? Am J Respir Crit Care Med 155(1): 104–108
Sharpley AL, Cowen PJ (1995) Effect of pharmacologic treatments on the sleep of depressed patients. Biol Psychiatry 37(2): 85–98
Shoham S, Davenne D, Cady AB, Dinarello CA, Krueger JM (1987) Recombinant tumor necrosis factor and interleukin 1 enhance slow-wave sleep. Am J Physiol 253 (1 Pt 2): R142–R149
Singer M, Romero B, Koenig E, Forstl H, Brunner H (2005) Albtraume bei Patienten mit Alzheimer-Demenz durch Donepezil. Therapeutischer Effekt ist abhängig vom Einnahmezeitpunkt. Nervenarzt (online publiziert)
Slatkin NE, Rhiner M (2003) Treatment of opiate-related sedation: utility of cholinesterase inhibitors. J Support Oncol 1(1): 53–63
Smith HS, Barton AE (2000) Tizanidine in the management of spasticity and musculoskeletal complaints in the palliative care population. Am J Hosp Palliat Care 17(1): 50–58
Sonntag A, Rothe B, Guldner J, Yassouridis A, Holsboer F, Steiger A (1996) Trimipramine and imipramine exert different effects on the sleep EEG and on nocturnal hormone secretion during treatment of major depression. Depression 4(1): 1–13
Spath-Schwalbe E, Lange T, Perras B, Fehm HL, Born J (2000) Interferon-alpha acutely impairs sleep in healthy humans. Cytokine 12(5): 518–521
Spiegel R, DeVos JE (1980) Central effects of guanfacine and clonidine during wakefulness and sleep in healthy subjects. Br J Clin Pharmacol 10(Suppl 1): 165S–168S
Squelart P, Saravia J (1977) Pipamperone (Dipiperon), a useful sedative neuroleptic drug in troublesome chronic psychotic patients. Acta Psychiatr Belg 77(2): 284–293
Staedt J, Stoppe G, Hajak G, Ruther E (1996) Rebound insomnia after abrupt clozapine withdrawl. Eur Arch Psychiatry Clin Neurosci 246(2): 79–82
Steiger A (2002) Sleep and hypothalamo-pituitary-adrenocortical system. Sleep Med Rev 6(2):125–138
Stoschitzky K, Sakotnik A, Lercher P, Zweiker R, Maier R, Liebmann P, Lindner W (1999) Influence of beta-blockers on melatonin release. Eur J Clin Pharmacol 55(2): 111–115
Swainston Harrison T, Keating GM (2005) Zolpidem: a review of its use in the management of insomnia. CNS Drugs 19(1): 65–89
Sweden B van (1987) Rebound insomnia in neuroleptic drug withdrawl neurophysiologic characteristics. Pharmacopsychiatry 20(3): 116–119
Takhar J, Bishop J (2000) Influence of chronic barbiturate administration on sleep apnea after hypersomnia presentation: case study. J Psychiatry Neurosci 25(4): 321–324
Tan A, Salgado M, Fahn S (1996) Rapid eye movement sleep behavior disorder preceding Parkinson’s disease with therapeutic response to levodopa. Mov Disord 11:214–216
Tanser PH, Campbell LM, Arrnza J, Karrash J, Toutouzas P, Watts R (2000) Candesartan cilexitil is not associated with cough in hypertensive patients with enalapril-induced cough. Multicentre Cough Study Group. Am J Hypertens 13(2): 214–218
Terao A, Matsumura H, Yoneda H, Saito M (1998) Enhancement of slow-wave sleep by tumor necrosis factor-alpha is mediated by cyclooxygenase-2 in rats. Neuroreport 9(17): 3791–3796
Touyz SW, Saayman GS, Zabow T (1978) A psychophysiological investigation of long-term effects of clozapine upon sleep patterns of normal young adults. Psychopharmacol 56: 69–73
Traub YM, Rosenfeld JB (1985) Comparison of low-dose captopril and propranolol as second-line drugs in mild and moderate hypertension. Isr J Md Sci 21(9): 737–741
Treiman DM, Pledger GW, DeGiorgo C, Tsay JY Cerghino JJ (1993) Increasing plasma concentration tolerability study of flunarizine in comedicated epileptic patients. Epilepsia 34(5): 944–953
Veronese ML, Gillen LP, Dorval EP, Hauck WW, Waldman SA, Greenberg HE (2003) Effect of mibrefadil on CYP3A4 in vivo. J Clin Pharmacol 43(10): 1091–1100
Vgontzas AN, Papanicolaou DA, Bixler EO, Lotsikas A, Zachman K, Prolo P, Wong ML, Licinio J, Gold PW, Hermida RC, Mastorakos G, Chrousos GP (1999) Circadian interleukin-6 secretion and quantity and depth of sleep. J Clin Endocrinol Metab 84(8): 2603–2607
Vgontzas AN, Zoumakis E, Lin HM, Bixler EO, Trakada G, Chrousos GP (2004) Marked decrease in sleepiness in patients with sleep apnea by etanercept, a tumor necrosis factor-alpha antagonist. J Clin Endocrinol Metab 89(9): 4409–4413
Walker BR, Hare LE, Deitch MW (1982) Comparative antihypertensive effects of guanabenz and clonidine. J Int Med Res 10(1): 6–14
Walker LG, Walker MB, Heyes SD, Lolley J, Wesnes K, Eremin O (1997) The psychological and psychiatric effects of rlL-2 therapy: a controlled clinical trial. Psychooncology 6(4): 290–300
Walther EU, Hohlfeld R (1999) Multiple sclerosis: side effects of interferon beta therapy and their management. Neurology 53(8): 1622–1627
Ware JC (1983) Tricyclic antidepressants in the treatment of insomnia. J Clin Psychiatry 44 (9 Pt 2): 25–28
Wetter TC, Lauer CJ, Gillich G, Pollmacher T (1996) The electroencephalographic sleep pattern in schizophrenic patients treated with clozapine or classical antipsychotic drugs. J Psychiatr Res 30(6): 411–419
Wetzel W (1990) Effect of repeated application of nootropic drugs on sleep in rats. Biomed Biochim Acta 49(5): 405–411
Whitlock FA, Evans LE (1978) Drugs and depression. Drugs 15(1): 53–71
Wiedemann K, Lauer C, Pollmacher T, Holsboer F (1994) Sleep endocrine effects of anti-gluco-and antimineralocorticoids in healthy males. Am J Physiol 267 (1 Pt 1): E109–114
Wiegand M, Berger M (1989) Action of trimipramine on sleep and pituitary hormone secretion. Drugs 38Suppl 1: 35–42
Williams MB, Jope RS (1994) Lithium potentiates phosphoinositide-linked 5-HT receptor stimulation in vivo. Neuroreport 5(9): 1118–1120
Wilson SJ, Bailey JE, Rich AS, Adrover M, Potokar J, Nutt DJ (2004) Using sleep to evaluate comparative serotonergic effects of paroxetine and citalopram. Eur Neuropsychopharmacol 14(5): 367–372
Winokur A, Gary KA, Rodner S, Rae-Red C, Fernando AT, Szuba MP (2001) Depression, sleep physiology, and antidepressant drugs. Depress Anxiety 14(1): 19–28
Wobrock T, Schwaab B, Bohm M, Schafers HJ, Wanke K, Supprian T (2001) Pharmacother-apeutical approaches to insomnia patients with cardiac diseases and after heart transplantation. Z Kardiol 90(10): 717–728
Wolf P, Roder-Wanner UU, Brede M (1984) Influence of therapeutic Phenobarbital and phenytoin medication on polygraphic sleep of patients with epilepsy. Epilepsia 25:467–475
Wong JO, Chiu GL, Tsao CJ, Chang CL (1997) Comparison of oral controlled-release morphine with transdermal fentanyl in terminal cancer pain. Acta Anaesthesiol Sin 35(1): 25–32
Wooten VD, Buysse DJ, Sleep in psychiatric disorders. In: Chokroverty S, Daroff RB (eds) (1999) Sleep disorders medicine. Boston (MA): Butterworth Heinemann: 573–586
Worth H, Muir JF, Pieters WR (2001) Comparison of hydrofluoroalkane-beclomethasone dipropionate Autohaler with budesonide Turbohaler in asthma control. Respiration 68(5): 517–526
Yodfat Y, Fidel J, Bloom DS (1985) Captopril as a replacement for multiple therapy in hypertension: a controlled study. J Hypertens Suppl 3(2): S155–S158
Youngchaiyud P, Permpikul C, Suthamsmai T, Wong E (1995) A double-blind comparison of inhaled budesonide, long-acting theophylline, and their combination in treatment of nocturnal asthma. Allergy 50(1): 28–33
Zachariah PK, Bonnet G, Chrysant SG et al. (1987) Evaluation of antihypertensive efficacy of lisinopril compared to metoprolol in moderate to severe hypertension. J Cardiovasc Pharmacol 9(Suppl 3): S53–S58
Zoltoski RK, Velazquez-Moctezuma J, Shiromani PJ, Gillin JC (1993) The relative effects of selective M1 muscarinic antagonists on rapid eye movement sleep. Brain Res 608(2): 186–190
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer Medizin Verlag Heidelberg
About this chapter
Cite this chapter
Schiefer, J. (2006). Schlafstörungen. In: Block, F., Prüter, C. (eds) Medikamentös induzierte neurologische und psychiatrische Störungen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-28604-7_7
Download citation
DOI: https://doi.org/10.1007/3-540-28604-7_7
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-28590-8
Online ISBN: 978-3-540-28604-2
eBook Packages: Medicine (German Language)